"Cannabinoid Receptor Antagonists"[nm] - Search Results

Year	Number of Results
2003	12
2004	41
2005	51
2006	58
2007	58
2008	63
2009	46
2010	39
2011	38
2012	85
2013	118
2014	89
2015	98
2016	74
2017	72
2018	69
2019	62
2020	55
2021	41
2022	19
2023	10
2024	2

1

Cannabinoid₁ (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose.

Skolnick P, Crystal R. Skolnick P, et al. J Neural Transm (Vienna). 2020 Feb;127(2):279-286. doi: 10.1007/s00702-019-02132-7. Epub 2019 Dec 31. J Neural Transm (Vienna). 2020. PMID: 31893308 Free PMC article. Review.

2

Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders.

Manera C, Arena C, Chicca A. Manera C, et al. Recent Pat CNS Drug Discov. 2016;10(2):142-156. doi: 10.2174/1574889810666160519113853. Recent Pat CNS Drug Discov. 2016. PMID: 27193072 Review.

3

A patent update on cannabinoid receptor 1 antagonists (2015-2018).

Amato G, Khan NS, Maitra R. Amato G, et al. Expert Opin Ther Pat. 2019 Apr;29(4):261-269. doi: 10.1080/13543776.2019.1597851. Epub 2019 Apr 8. Expert Opin Ther Pat. 2019. PMID: 30889997 Free PMC article. Review.

4

New cannabinoid receptor antagonists as pharmacological tool.

González-Naranjo P, Pérez C, Girón R, Sánchez-Robles EM, Martín-Fontelles MI, Carrillo-López N, Martín-Vírgala J, Naves M, Campillo NE, Páez JA. González-Naranjo P, et al. Bioorg Med Chem. 2020 Oct 1;28(19):115672. doi: 10.1016/j.bmc.2020.115672. Epub 2020 Jul 29. Bioorg Med Chem. 2020. PMID: 32912440

5

Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.

Morales P, Hernandez-Folgado L, Goya P, Jagerovic N. Morales P, et al. Expert Opin Ther Pat. 2016 Jul;26(7):843-56. doi: 10.1080/13543776.2016.1193157. Epub 2016 Jun 7. Expert Opin Ther Pat. 2016. PMID: 27215781 Review.

6

Endothelial atypical cannabinoid receptor: do we have enough evidence?

Bondarenko AI. Bondarenko AI. Br J Pharmacol. 2014 Dec;171(24):5573-88. doi: 10.1111/bph.12866. Br J Pharmacol. 2014. PMID: 25073723 Free PMC article. Review.

7

Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists.

Hsiao WC, Hsin KY, Wu ZW, Song JS, Yeh YN, Chen YF, Tsai CH, Chen PH, Shia KS, Chang CP, Hung MS. Hsiao WC, et al. Bioorg Chem. 2023 Jan;130:106236. doi: 10.1016/j.bioorg.2022.106236. Epub 2022 Nov 4. Bioorg Chem. 2023. PMID: 36371817

8

Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Galaj E, Xi ZX. Galaj E, et al. CNS Drugs. 2019 Oct;33(10):1001-1030. doi: 10.1007/s40263-019-00664-w. CNS Drugs. 2019. PMID: 31549358 Free PMC article. Review.

9

A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents.

Sharma MK, Murumkar PR, Barmade MA, Giridhar R, Yadav MR. Sharma MK, et al. Expert Opin Ther Pat. 2015;25(10):1093-116. doi: 10.1517/13543776.2015.1064898. Epub 2015 Jul 10. Expert Opin Ther Pat. 2015. PMID: 26161824 Review.

10

Advances in patented CB1 receptor antagonists for obesity.

Yadav MR, Murumkar PR. Yadav MR, et al. Pharm Pat Anal. 2018 Sep;7(5):169-173. doi: 10.4155/ppa-2018-0020. Epub 2018 Aug 1. Pharm Pat Anal. 2018. PMID: 30066594 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,020 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,020 results

Results by year